RAPTIVA

Welcome to the Brand page for “RAPTIVA”, which is offered here for In the statement, column 1, lines 6-8, cardiovascular diseases and disorders, oncological diseases and disorders is deleted. column 1, lines 9-10, andiogenesis diseases and disorders, ocular diseases and disorders is deleted. column 2, line 1, including crohn's disease is deleted.;pharmaceutical preparations for the treatment of [ cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, angiogenesis diseases and disorders, ocular diseases and disorders, ] and inflammatory diseases and disorders [ including crohn's disease, ] all of the above excluding the treatment of gastrointestinal problems and diseases;.

Its status is currently believed to be active. Its class is unavailable. “RAPTIVA” is believed to be currently owned by “GENENTECH, INC.”